Abstract
The authors assessed the prevalence of headaches following extended-release dipyridamole/aspirin combination (DAC), and the efficacy of acetaminophen in the treatment of these headaches. Following DAC, 38.7% of the participants developed headaches. The headaches were self-limited (69.4% placebo efficacy in 2 hours) and the incidence markedly declined over time. Acetaminophen was no more effective than placebo in the acute and preemptive treatment of these headaches.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1099-1101 |
| Number of pages | 3 |
| Journal | Neurology |
| Volume | 63 |
| Issue number | 6 |
| State | Published - Sep 29 2004 |
Fingerprint
ASJC Scopus subject areas
- Neuroscience(all)
Cite this
Acetaminophen in the treatment of headaches associated with dipyridamole-aspirin combination. / Lipton, Richard B.; Bigal, M. E.; Kolodner, K. B.; Gorelick, P. B.; Wilks, K.; Schoebelock, M.; Davidai, G.
In: Neurology, Vol. 63, No. 6, 29.09.2004, p. 1099-1101.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Acetaminophen in the treatment of headaches associated with dipyridamole-aspirin combination
AU - Lipton, Richard B.
AU - Bigal, M. E.
AU - Kolodner, K. B.
AU - Gorelick, P. B.
AU - Wilks, K.
AU - Schoebelock, M.
AU - Davidai, G.
PY - 2004/9/29
Y1 - 2004/9/29
N2 - The authors assessed the prevalence of headaches following extended-release dipyridamole/aspirin combination (DAC), and the efficacy of acetaminophen in the treatment of these headaches. Following DAC, 38.7% of the participants developed headaches. The headaches were self-limited (69.4% placebo efficacy in 2 hours) and the incidence markedly declined over time. Acetaminophen was no more effective than placebo in the acute and preemptive treatment of these headaches.
AB - The authors assessed the prevalence of headaches following extended-release dipyridamole/aspirin combination (DAC), and the efficacy of acetaminophen in the treatment of these headaches. Following DAC, 38.7% of the participants developed headaches. The headaches were self-limited (69.4% placebo efficacy in 2 hours) and the incidence markedly declined over time. Acetaminophen was no more effective than placebo in the acute and preemptive treatment of these headaches.
UR - http://www.scopus.com/inward/record.url?scp=4644266898&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=4644266898&partnerID=8YFLogxK
M3 - Article
C2 - 15452309
AN - SCOPUS:4644266898
VL - 63
SP - 1099
EP - 1101
JO - Neurology
JF - Neurology
SN - 0028-3878
IS - 6
ER -